Nicotine withdrawal

Nicotine withdrawal occurs when a person who regularly uses tobacco products suddenly stops or reduces their nicotine intake. This condition primarily affects the nervous system, as nicotine acts on brain receptors that regulate mood and reward. When nicotine is absent, the brain experiences a chemical imbalance leading to symptoms such as irritability, anxiety, difficulty concentrating, and strong cravings for tobacco. Physical symptoms can include increased appetite and sleep disturbances. These effects can make quitting smoking challenging and impact overall health by increasing stress and discomfort during the withdrawal period.

Nicotine withdrawal is a clinical syndrome characterized by a constellation of psychological and physical symptoms that arise after abrupt cessation or reduction of chronic nicotine use. The core pathology involves the sudden absence of nicotine stimulation on nicotinic acetylcholine receptors in the central nervous system, leading to dysregulation of neurotransmitters such as dopamine and acetylcholine. This neurochemical imbalance manifests as cravings, mood disturbances, and autonomic symptoms. It is a major component of tobacco use disorder and contributes significantly to relapse risk. The syndrome typically begins within hours of cessation and peaks within the first week, with symptoms gradually resolving over several weeks. Recognition of this syndrome is critical for effective management of tobacco dependence.